tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Savara price target lowered to $7 from $8 at Wells Fargo
PremiumThe FlySavara price target lowered to $7 from $8 at Wells Fargo
2M ago
U.S. extends EU tariff deadline, Salesforce to acquire Informatica: Morning Buzz
Premium
The Fly
U.S. extends EU tariff deadline, Salesforce to acquire Informatica: Morning Buzz
2M ago
Savara Faces FDA Setback for MOLBREEVI Application
Premium
Company Announcements
Savara Faces FDA Setback for MOLBREEVI Application
2M ago
Savara reports Q1 EPS (12c), consensus (13c)
PremiumThe FlySavara reports Q1 EPS (12c), consensus (13c)
2M ago
Savara announces encore presentations from Molgramostim Phase 3 IMPALA-2 trial
Premium
The Fly
Savara announces encore presentations from Molgramostim Phase 3 IMPALA-2 trial
4M ago
Savara’s Strategic Advancements and Market Potential of Molbreevi: A Transformative Approach to aPAP Treatment
Premium
Ratings
Savara’s Strategic Advancements and Market Potential of Molbreevi: A Transformative Approach to aPAP Treatment
4M ago
Savara’s Innovative Testing and BLA Submission Drive Buy Rating Amid Market Growth Potential
PremiumRatingsSavara’s Innovative Testing and BLA Submission Drive Buy Rating Amid Market Growth Potential
5M ago
Savara Sets 2025 Executive Bonus Targets
Premium
Company Announcements
Savara Sets 2025 Executive Bonus Targets
6M ago
Savara Highlights MOLBREEVI’s Potential in Rare Disease Market
Premium
Company Announcements
Savara Highlights MOLBREEVI’s Potential in Rare Disease Market
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100